Image

Endovascular Embolization for Chronic Subdural Hematomas Following Surgical Evacuation

A study on treating brain bleeds after surgery with endovascular embolization.

Recruiting
18-90 years
All
Phase N/A

Study Overview: This research looks at a new way to treat chronic subdural hematomas (SDHs), which are blood clots under the brain's outer covering. Normally, surgery is done to remove these clots. However, some patients, especially older ones, face high risks with surgery and the clots often come back. This study explores adding endovascular embolization after surgery, a less invasive procedure where doctors block blood flow in the middle meningeal artery to reduce clot recurrence.

Key Details:

  • The study is for patients aged 18-90 who have undergone surgery for SDHs.
  • Participants will be randomly placed in two groups: one will have surgery only, and the other will have surgery plus embolization.
  • The study aims to see if the combination treatment reduces hospital stays, recurrences, and surgeries.

Eligibility: To join, patients must be between 18 and 90 years old, need surgery for SDH, and be in relatively stable condition as per medical scales. Exclusions include pregnancy, severe trauma, serious kidney or liver problems, and certain bleeding disorders. Participants must be able to consent or have a legal representative available.

Study details
    Chronic SDH and the Efficacy of Embolization

NCT04272996

Augusta University

12 October 2024

Step 1 Get in touch with the nearest study center
What happens next?
  • You can expect the study team to contact you via email or phone in the next few days.
  • Sign up as volunteer  to help accelerate the development of new treatments and to get notified about similar trials.

You are contacting

Investigator Avatar

Primary Contact

site

  Other languages supported:

FAQs

Learn more about clinical trials

What is a clinical trial?

A clinical trial is a study designed to test specific interventions or treatments' effectiveness and safety, paving the way for new, innovative healthcare solutions.

Why should I take part in a clinical trial?

Participating in a clinical trial provides early access to potentially effective treatments and directly contributes to the healthcare advancements that benefit us all.

How long does a clinical trial take place?

The duration of clinical trials varies. Some trials last weeks, some years, depending on the phase and intention of the trial.

Do I get compensated for taking part in clinical trials?

Compensation varies per trial. Some offer payment or reimbursement for time and travel, while others may not.

How safe are clinical trials?

Clinical trials follow strict ethical guidelines and protocols to safeguard participants' health. They are closely monitored and safety reviewed regularly.
Add a private note
  • abc Select a piece of text.
  • Add notes visible only to you.
  • Send it to people through a passcode protected link.